Back to search

Article

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

2024-05-14

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> NK cells are being extensively studied as a cell therapy for cancer. Their effector functions are induced by the recognition of ligands on tumor cells and by various cytokines. IL-15 is broadly used to stimulate endogenous and adoptively transferred NK cells in cancer patients. These stimuli activate the membrane protease ADAM17, which then cleaves assorted receptors on the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7ce01e97-f08b-5647-841b-4e0c8287a1d5
DOI
10.1101/2024.05.09.593347
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsDOI 10.1101/2024.05.09.593347
Select a neighboring publication to make it the new centre.